EuroNanoMedicine 2009, 28-30.9, Bled

Mankind is still fighting against a high number of serious and complex illnesses like cancer, cardiovascular diseases, multiple sclerosis, Alzheimer’s and Parkinson’s disease, and diabetes as well as different kinds of serious inflammatory or infectious diseases (e.g. HIV).

Several areas of medical care are already benefiting from the advantages that nanotechnology can offer. I.e., the first nanotechnology-based targeted drug delivery systems are already on the market, others are in clinical trials or, by far the largest part, are under development. The promising possibilities that nanomedicine might offer in the future have to be counterweighted against possible risks of this new technology. It is of utmost importance to examine upfront with care and responsibility its possible side effects to human beings and the environment.

The programme of this conference will cover current topics and recent progress in this highly challenging topic. In detail all aspects of targeted nanomedicine and therapeutic concepts, overcoming biological barriers, medical diagnostics and sensor devices, nanomedicine and regenerative medicine, nanomedicines for gene delivery, and safety aspects of nanomaterials for medical applications will be addressed.